Sartorius Stedim Biotech (Sartorius Stedim Biotech) EPS (Basic) : $3.62 (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech EPS (Basic)?

Sartorius Stedim Biotech's basic earnings per share (Basic EPS) for the three months ended in Dec. 2023 was $0.47. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.62.

Sartorius Stedim Biotech's EPS (Diluted) for the three months ended in Dec. 2023 was $0.47. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.62.

Sartorius Stedim Biotech's EPS without NRI for the three months ended in Dec. 2023 was $0.47. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 3.62.

During the past 12 months, Sartorius Stedim Biotech's average EPS without NRIGrowth Rate was -66.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -9.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sartorius Stedim Biotech's highest 3-Year average EPS without NRI Growth Rate was 82.90% per year. The lowest was -16.10% per year. And the median was 27.00% per year.

Sartorius Stedim Biotech EPS (Basic) Historical Data

The historical data trend for Sartorius Stedim Biotech's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech EPS (Basic) Chart

Sartorius Stedim Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

2.82

4.43

5.09

10.07

3.66

Sartorius Stedim Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															2.19	1.30	1.56	0.30	0.47

Sartorius Stedim Biotech EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sartorius Stedim Biotech's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(337.732	-	0)	/	92.161
	=	3.66

Sartorius Stedim Biotech's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(43.402	-	0)	/	92.294
	=	0.47

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.62

Sartorius Stedim Biotech (OTCPK:SDMHF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Sartorius Stedim Biotech EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech (Sartorius Stedim Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

SRTOY:USA DIM:Mexico DIMp:UK 0RG8:UK DIM:France 56S1:Germany

Address

Otto-Brenner-Strasse 20, Goettingen, DEU, 37079

Website

https://www.sartorius.com

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.